The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

The Biden administration’s drug-price negotiation law threatens new product development and will lead to fewer new medicines ...

Kaleb Johnson uses his speed to outrun the Minnesota defense and score a 40-yard touchdown in the third quarter, giving Iowa ...

Daratumumab is under clinical development by Johnson & Johnson and currently in Phase II for Lupus Nephritis. According to GlobalData, Phase II drugs for Lupus Nephritis have a 50% phase transition ...

In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...

Johnson & Johnson (JNJ) closed the most recent trading day at $166.61, moving +1.36% from the previous trading session. This move outpaced the S&P 500's daily gain of 1.16%. At the same time, the Dow ...

Iowa RB Kaleb Johnson recorded a career-high 206 yards and three touchdowns to help lead Iowa to a 31-14 victory over ...

Erdafitinib is under clinical development by Johnson & Johnson and currently in Phase II for Soft Tissue Sarcoma.

Johnson Controls (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, is showcasing its industry ...

The pro dancer also previews her partnership with Joey Graziadei, saying the Bachelor is 'humble and hardworking.' ...

Today, we are looking at leisure products stocks, starting with Johnson Outdoors (NASDAQ:JOUT). Leisure products cover a wide range of goods in the consumer discretionary sector. Maintaining a ...